Pharma Foods International Co Ltd
TSE:2929

Watchlist Manager
Pharma Foods International Co Ltd Logo
Pharma Foods International Co Ltd
TSE:2929
Watchlist
Price: 1 003 JPY 6.93%
Market Cap: 28.2B JPY
Have any thoughts about
Pharma Foods International Co Ltd?
Write Note

Pharma Foods International Co Ltd
Other Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Pharma Foods International Co Ltd
Other Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Pharma Foods International Co Ltd
TSE:2929
Other Current Assets
ÂĄ846m
CAGR 3-Years
21%
CAGR 5-Years
19%
CAGR 10-Years
18%
GNI Group Ltd
TSE:2160
Other Current Assets
ÂĄ1.3B
CAGR 3-Years
24%
CAGR 5-Years
34%
CAGR 10-Years
28%
PeptiDream Inc
TSE:4587
Other Current Assets
ÂĄ1B
CAGR 3-Years
46%
CAGR 5-Years
29%
CAGR 10-Years
35%
Takara Bio Inc
TSE:4974
Other Current Assets
ÂĄ1.9B
CAGR 3-Years
15%
CAGR 5-Years
8%
CAGR 10-Years
0%
S
StemRIM Inc
TSE:4599
Other Current Assets
ÂĄ437.7m
CAGR 3-Years
12%
CAGR 5-Years
22%
CAGR 10-Years
N/A
C
Cuorips Inc
TSE:4894
Other Current Assets
ÂĄ28.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Pharma Foods International Co Ltd
Glance View

Market Cap
28.1B JPY
Industry
Biotechnology

Pharma Foods International Co., Ltd. engages in the development and sale of functional food materials. The company is headquartered in Kyoto, Kyoto-Fu and currently employs 293 full-time employees. The company went IPO on 2006-06-12. The firm operates through three business segments. The Mail Order segment is engaged in the sale of supplement Tamagosamin, cosmetics Pearl Skin Lanchel and Derma QII Mild Peeling Gel, through advertising media such as televisions and radios. The Functional Materials segment is engaged in the development and sale of functional materials such as GABA, Bonepep, Folic Acid eggs and Chicken Egg Antibody. The firm is also engaged in the planning and sale of original equipment manufacturer (OEM) products such as supplements and beverages. The Biomedical segment is engaged in the antibody contract manufacture business for drug discovery and diagnostics, and life science information (LSI) business for analysis and efficacy evaluation test of materials and products.

Intrinsic Value
2 599.9 JPY
Undervaluation 61%
Intrinsic Value
Price

See Also

What is Pharma Foods International Co Ltd's Other Current Assets?
Other Current Assets
846m JPY

Based on the financial report for Oct 31, 2024, Pharma Foods International Co Ltd's Other Current Assets amounts to 846m JPY.

What is Pharma Foods International Co Ltd's Other Current Assets growth rate?
Other Current Assets CAGR 10Y
18%

Over the last year, the Other Current Assets growth was 17%. The average annual Other Current Assets growth rates for Pharma Foods International Co Ltd have been 21% over the past three years , 19% over the past five years , and 18% over the past ten years .

Back to Top